← FDA DRUG APPROVALS

FDA ANDA · ANDA210332

LACTATED RINGERS AND DEXTROSE

sodium chloride, sodium lactate, potassium chloride, calcium chloride, and dextrose monohydrate

Sponsor: FRESENIUS KABI USA

APPLICATION
ANDA210332
TYPE
ANDA
ORIGINAL APPROVAL
2022-03-28
LATEST ACTION
2022-12-22
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

DEXTROSE 5% AND LACTATED RINGER'SPrescription
CALCIUM CHLORIDE 20MG/100ML, DEXTROSE 5GM/100ML, POTASSIUM CHLORIDE 30MG/100ML, SODIUM CHLORIDE 600MG/100ML, SODIUM LACTATE 310MG/100ML · INJECTABLE · INJECTION

Approval history

2022-12-22Manufacturing (CMC) · Supplement 1 · unknownAP
2022-03-28UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →